{"id":"https://openalex.org/W2394626707","doi":null,"title":"Strategies for the discovery of novel tyrosine kinase inhibitors with anticancer activity.","display_name":"Strategies for the discovery of novel tyrosine kinase inhibitors with anticancer activity.","alternate_titles":[],"publication_year":1994,"publication_date":"1994-08-01","ids":{"openalex":"https://openalex.org/W2394626707","mag":"2394626707","pmid":"https://pubmed.ncbi.nlm.nih.gov/7916900"},"language":"en","primary_location":{"id":"pmid:7916900","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7916900","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drug design","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2394626707"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033059231","display_name":"David W. Fry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D W Fry","raw_affiliation_strings":["Department of Cancer Research, Parke-Davis Pharmaceutical Research, Warner-Lambert Company, Ann Arbor, MI 48105"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Research, Parke-Davis Pharmaceutical Research, Warner-Lambert Company, Ann Arbor, MI 48105","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071126343","display_name":"A. J. Kraker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A J Kraker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024497408","display_name":"R. C. Connors","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R C Connors","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111938007","display_name":"William L. Elliott","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W L Elliott","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111847108","display_name":"J. Nelson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J M Nelson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112448467","display_name":"H. D. Hollis Showalter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H D Showalter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110908562","display_name":"Wilbur R. Leopold","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W R Leopold","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.8039,"has_fulltext":false,"cited_by_count":39,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96156113,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":92},"biblio":{"volume":"9","issue":"4","first_page":"331","last_page":"351"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.551800012588501,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.551800012588501,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.24899999797344208,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.14229999482631683,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":1.0},{"id":"https://openalex.org/keywords/anticancer-drug-discovery","display_name":"anticancer drug discovery","score":0.8479999899864197},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.890999972820282},{"id":"https://openalex.org/keywords/enzyme-specificity","display_name":"enzyme specificity","score":0.8379999995231628},{"id":"https://openalex.org/keywords/tyrosine-phosphorylation","display_name":"tyrosine phosphorylation","score":0.9430000185966492},{"id":"https://openalex.org/keywords/mitogenesis","display_name":"mitogenesis","score":0.9480000138282776},{"id":"https://openalex.org/keywords/signal-transduction-inhibition","display_name":"signal transduction inhibition","score":0.7279999852180481},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7639999985694885},{"id":"https://openalex.org/keywords/in-vivo-tumor-model","display_name":"in vivo tumor model","score":0.9129999876022339},{"id":"https://openalex.org/keywords/dose-scheduling","display_name":"dose scheduling","score":0.5}],"concepts":[{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.6302251815795898},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.6237524747848511},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.618378758430481},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.581351101398468},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.5230713486671448},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4419867694377899},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4396677017211914},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4288632869720459},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3850248456001282},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.38024574518203735},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0824771523475647}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010982","descriptor_name":"Platelet-Derived Growth Factor","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014443","descriptor_name":"Tyrosine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016222","descriptor_name":"Fibroblast Growth Factor 2","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D016475","descriptor_name":"3T3 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:7916900","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7916900","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drug design","raw_type":"Journal Article"},{"id":"mag:2394626707","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7916900","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2156129904","https://openalex.org/W1566148925","https://openalex.org/W2004309367","https://openalex.org/W2032861503","https://openalex.org/W3021006293","https://openalex.org/W2060647267","https://openalex.org/W2359748835","https://openalex.org/W2949609520","https://openalex.org/W2014868419"],"abstract_inverted_index":{"We":[0],"present":[1],"a":[2,58,85,182,202],"general":[3],"drug":[4,194],"discovery":[5],"strategy":[6],"to":[7,196],"find":[8],"novel":[9],"inhibitors":[10,136],"of":[11,19,28,50,62,70,73,137,146,193,205,212],"tyrosine":[12,63,77,104],"kinases.":[13],"This":[14],"scheme":[15],"includes":[16],"the":[17,66,96,123,126,189,206],"production":[18],"initial":[20],"protein":[21],"targets":[22],"for":[23,46,118,171,184,208],"primary":[24],"screening,":[25],"an":[26,142],"evaluation":[27,49,195],"enzyme":[29,92],"potency":[30],"and":[31,34,44,83,106,153,175,200],"specificity,":[32],"biochemical":[33],"biological":[35],"effects":[36,120],"on":[37,95,122,125],"various":[38],"cellular":[39],"processes":[40],"in":[41,47,108,112,159,190],"whole-cell":[42],"models,":[43],"strategies":[45],"vivo":[48,160,191],"antitumor":[51,148],"activity.":[52],"These":[53,99,178],"aspects":[54],"are":[55],"illustrated":[56],"using":[57],"newly":[59],"discovered":[60],"class":[61,72,145],"kinase":[64],"inhibitors,":[65],"2-thioindoles.":[67],"Certain":[68],"members":[69],"this":[71],"compounds":[74,100],"inhibit":[75],"specific":[76],"kinases":[78],"at":[79,188],"low":[80],"micromolar":[81],"concentrations":[82],"exhibit":[84,115],"distinct":[86,150],"structure-activity":[87],"relationship,":[88],"as":[89,91,166,168],"well":[90,167],"specificity":[93,117],"depending":[94,121],"chemical":[97],"substitution.":[98],"suppress":[101],"growth":[102],"factor-mediated":[103],"phosphorylation":[105],"mitogenesis":[107],"viable":[109],"cells":[110],"and,":[111],"some":[113],"cases,":[114],"marked":[116],"these":[119,209],"substituents":[124],"indole":[127],"ring":[128],"system.":[129],"The":[130],"issue":[131],"is":[132],"stressed":[133],"that":[134],"since":[135],"signal":[138],"transduction":[139],"pathways":[140],"represent":[141],"entirely":[143],"new":[144],"potential":[147],"agents,":[149],"from":[151],"past":[152],"currently":[154],"used":[155],"cancer":[156],"therapies,":[157],"alternative":[158],"tumor":[161],"models":[162],"may":[163],"be":[164],"needed":[165],"different":[169],"requirements":[170],"dose":[172],"levels,":[173],"scheduling":[174],"endpoint":[176],"evaluation.":[177],"inherent":[179],"difficulties":[180],"emphasize":[181],"need":[183],"more":[185],"basic":[186],"research":[187],"stage":[192],"enhance":[197],"model":[198],"development":[199],"provide":[201],"better":[203],"understanding":[204],"pharmacology":[207],"newer":[210],"classes":[211],"drugs.":[213]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2394626707","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
